These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 11162543

  • 1. VEGF can act as vascular permeability factor in the hepatic sinusoids through upregulation of porosity of endothelial cells.
    Funyu J, Mochida S, Inao M, Matsui A, Fujiwara K.
    Biochem Biophys Res Commun; 2001 Jan 19; 280(2):481-5. PubMed ID: 11162543
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of hepatic stellate cell contraction during activation in vitro by vascular endothelial growth factor in association with upregulation of FLT tyrosine kinase receptor family, FLT-1.
    Mashiba S, Mochida S, Ishikawa K, Inao M, Matsui A, Ohno A, Ikeda H, Nagoshi S, Shibuya M, Fujiwara K.
    Biochem Biophys Res Commun; 1999 May 19; 258(3):674-8. PubMed ID: 10329444
    [Abstract] [Full Text] [Related]

  • 3. The mechanisms of hepatic sinusoidal endothelial cell regeneration: a possible communication system associated with vascular endothelial growth factor in liver cells.
    Mochida S, Ishikawa K, Toshima K, Inao M, Ikeda H, Matsui A, Shibuya M, Fujiwara K.
    J Gastroenterol Hepatol; 1998 Sep 19; 13 Suppl():S1-5. PubMed ID: 9792028
    [Abstract] [Full Text] [Related]

  • 4. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells.
    Watanabe Y, Lee SW, Detmar M, Ajioka I, Dvorak HF.
    Oncogene; 1997 May 01; 14(17):2025-32. PubMed ID: 9160882
    [Abstract] [Full Text] [Related]

  • 5. The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model.
    Yoshiji H, Kuriyama S, Hicklin DJ, Huber J, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H.
    Hepatology; 2001 Apr 01; 33(4):841-7. PubMed ID: 11283848
    [Abstract] [Full Text] [Related]

  • 6. Glycine prevents apoptosis of rat sinusoidal endothelial cells caused by deprivation of vascular endothelial growth factor.
    Zhang Y, Ikejima K, Honda H, Kitamura T, Takei Y, Sato N.
    Hepatology; 2000 Sep 01; 32(3):542-6. PubMed ID: 10960447
    [Abstract] [Full Text] [Related]

  • 7. Ex vivo expression of angiogenic growth factors and their receptors in human penile cavernosal cells.
    Rajasekaran M, Kasyan A, Allilain W, Monga M.
    J Androl; 2003 Sep 01; 24(1):85-90. PubMed ID: 12514088
    [Abstract] [Full Text] [Related]

  • 8. Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade.
    Pal S, Iruela-Arispe ML, Harvey VS, Zeng H, Nagy JA, Dvorak HF, Mukhopadhyay D.
    Microvasc Res; 2000 Sep 01; 60(2):112-20. PubMed ID: 10964585
    [Abstract] [Full Text] [Related]

  • 9. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis.
    Olaso E, Salado C, Egilegor E, Gutierrez V, Santisteban A, Sancho-Bru P, Friedman SL, Vidal-Vanaclocha F.
    Hepatology; 2003 Mar 01; 37(3):674-85. PubMed ID: 12601365
    [Abstract] [Full Text] [Related]

  • 10. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.
    Wang J, Morita I, Onodera M, Murota SI.
    J Cell Physiol; 2002 Feb 01; 190(2):238-50. PubMed ID: 11807828
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma.
    Strizzi L, Catalano A, Vianale G, Orecchia S, Casalini A, Tassi G, Puntoni R, Mutti L, Procopio A.
    J Pathol; 2001 Apr 01; 193(4):468-75. PubMed ID: 11276005
    [Abstract] [Full Text] [Related]

  • 12. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D, Jimenez X, Zhang H, Wu Y, Bohlen P, Witte L, Zhu Z.
    Cancer Res; 2001 Oct 01; 61(19):7002-8. PubMed ID: 11585724
    [Abstract] [Full Text] [Related]

  • 13. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y.
    Diabetologia; 2003 Jan 01; 46(1):115-23. PubMed ID: 12637990
    [Abstract] [Full Text] [Related]

  • 14. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R, Gingras D, Kruger EA, Lamy S, Sirois P, Simard B, Sirois MG, Tranqui L, Baffert F, Beaulieu E, Dimitriadou V, Pépin MC, Courjal F, Ricard I, Poyet P, Falardeau P, Figg WD, Dupont E.
    Clin Cancer Res; 2002 Apr 01; 8(4):1242-50. PubMed ID: 11948139
    [Abstract] [Full Text] [Related]

  • 15. Tamoxifen inhibits endothelial cell proliferation and attenuates VEGF-mediated angiogenesis and migration in vivo.
    McNamara DA, Harmey J, Wang JH, Kay E, Walsh TN, Bouchier-Hayes DJ.
    Eur J Surg Oncol; 2001 Dec 01; 27(8):714-8. PubMed ID: 11735166
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R, Böger RH, Ergün S, Steenpass A, Wieland T.
    Circ Res; 2003 Sep 05; 93(5):438-47. PubMed ID: 12881481
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM.
    Medicina (B Aires); 2000 Sep 05; 60 Suppl 2():41-7. PubMed ID: 11188930
    [Abstract] [Full Text] [Related]

  • 18. VEGF and VEGF receptor levels in retinal and brain-derived endothelial cells.
    Rajah TT, Grammas P.
    Biochem Biophys Res Commun; 2002 May 03; 293(2):710-3. PubMed ID: 12054527
    [Abstract] [Full Text] [Related]

  • 19. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
    Pal S, Datta K, Mukhopadhyay D.
    Cancer Res; 2001 Sep 15; 61(18):6952-7. PubMed ID: 11559575
    [Abstract] [Full Text] [Related]

  • 20. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
    Jackson MW, Roberts JS, Heckford SE, Ricciardelli C, Stahl J, Choong C, Horsfall DJ, Tilley WD.
    Cancer Res; 2002 Feb 01; 62(3):854-9. PubMed ID: 11830543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.